Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

4

Revenue 2017

Herceptin

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Herceptin was produced by Roche.

Roche posts minor sales miss in Q4 as biosimilar pressure grows

Roche posts minor sales miss in Q4 as biosimilar pressure grows All told, the Swiss group’s pharma sales came in at CHF 12bn ($12.35bn), with its ‘big three’ antibodies – Avastin (bevacizumab), Herceptin (trastuzumab) and Rituxan/MabThera (rituximab) – all on the ... Perjeta – used as an add-on to

AZ, Daiichi Sankyo’s Enhertu set fair for filing in gastric cancer

AZ, Daiichi Sankyo’s Enhertu set fair for filing in gastric cancer Enhertu (trastuzumab-deruxtecan) – which combines the antibody component of Roche’s HER2 cancer drug Herceptin with a chemotherapy payload – was  approved by the FDA last month for heavily pre-treated breast ... prior treatment regimens including

AZ, Daiichi Sankyo get early okay for DS-8201, now named Enhertu

AZ, Daiichi Sankyo get early okay for DS-8201, now named Enhertu This first regulatory approval is based on the DESTINY-Breast01 trial in patients who had previously been treated with Herceptin, Perjeta or Kadcyla. ... cancer, in addition to its established use as an  adjuvant treatment in patients who fail Herceptin

EMA backs adjuvant use of Roche’s breast cancer ADC Kadcyla

EMA backs adjuvant use of Roche’s breast cancer ADC Kadcyla cancer cells despite treatment before surgery with taxane and other  HER2 drugs like Roche’s Herceptin (trastuzumab). ... from its other use in patients who relapse after or don’t respond to Herceptin.

AZ, Daiichi Sankyo strengthen case for HER2 candidate

AZ, Daiichi Sankyo strengthen case for HER2 candidate Kadcyla is the smallest in terms of sales in Roche’s HER2 franchise, with its sales falling behind those of Herceptin (trastuzumab) and Perjeta (pertuzumab). ... lines of treatment, to become a direct challenger to Roche’s Herceptin/Perjeta

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...

Infographics